Study Goals
The major goals of the study on non-syndromic hearing loss (NSHL) at The Rockefeller University are: to localize novel NSHL gene(s); refine the genetic region for known NSHL loci; and isolate NSHL genes. This study offers the basic research which will aid in understanding the function of genes controlling the mechanism of hearing. This knowledge in turn should facilitate the development of intervention strategies to prevent and treat hearing loss.
Background Information on Non-Syndromic Hearing Loss (updated 3/8/04)
Hearing impairment, which ranges in severity from modest difficulty with speech comprehension through profound hearing loss, affects 28 million Americans. Approximately one in every thousand children is born with a significant hearing impairment. An additional 1/1,000 children become severely hearing impaired before adulthood (Morton 1991; Reardon 1992). More than 60 percent of the cases of profound early-onset deafness are caused by genetic factors, which in most cases are due to single gene mutations (Marazita et al. 1993). About 75 percent of individuals with genetically determined deafness have no other clinical features, the other 25% have identifiable syndromes (Morton 1991; Reardon 1992; Marazita et al. 1993). It is estimated that approximately 75% of cases display autosomal recessive inheritance, 15% of cases are autosomal dominant and 2-3% cases are X-linked (Fraser 1976). NSHL can also be due to mitochondrial inheritance (Prezant et al. 1993).
It is estimated that for NSRHL (autosomal recessive NSHL) there are between 30-100 genes (Chung et al. 1959, Morton 1991). Over 60 NSHL loci have been localized (33 autosomal dominant loci [DFNA], 29 autosomal recessive loci [DFNB] and 5 X-linked loci [DFN]). Twenty one genes have been identified.
Table 1: Identified Genes for Non-sydromic Hearing Loss. Table 1
Gene |
OMIM |
Encoded Product |
Loci |
Position |
Reference |
ACTG1 |
DFNA20/26 |
17q25.3 |
|||
CDH23 |
Cadherin-23(otocadherin) |
DFNB12 |
10q22.1 |
||
CLDN14 |
Claudin-14 |
DFNB29 |
21q22.13 |
||
COCH |
COCH |
DFNA9 |
14q12 |
||
COL11A2 |
Collagen, type XI |
DFNA13 |
6p21.32 |
||
CRYM |
CRYSTALLIN |
|
16p13.11-p12.3 |
||
DFNA5 |
DFNA5 |
DFNA5 |
7p15.3 |
||
DIAPH1 |
Diaphanous 1 |
DFNA1 |
5q31.3 |
||
EYA4 |
601316 | EYA (Eye Absent - transcriptonal act.) | DFNA10 | 6q23.2 |
Wayne el at. 2001 |
| GJA1 | 121014 | connexin 43 | 6q22.31 |
Liu et al. 2001 | |
GJB2 (Cx26) |
Connexin 26 |
DFNA3 |
13q12.11 |
||
GJB3 (Cx31) |
Connexin 31 |
DFNA2 |
1p34.3 |
||
GJB6 (Cx30) |
Connexin 30 |
DFNA3 |
13q12.11 |
||
| HARMONIN | 605242 | HARMONIN | DFNB18 | 11p15.1 |
Ahmed et al, 2002 |
KCNQ4 |
KCNQ4 |
DFNA2 |
1p34.2 |
||
MYH9 |
Myosin-9 |
DFNA17 |
22q12.3 |
||
MYO1A |
Myosin IA |
DFNA48 |
12q13.3 |
||
| MYO3A | 606808 | Myosin IIIA | DFNB30 | 10q11.1 |
Walsh et al. 2002 |
| MYO6 | 600970 | Myosin-VI | DFNA22 DFNB37 |
6q14.1 |
Melchionda
et al. 2001 Ahmed et al, 2003 |
MYO7A |
Myosin VIIA |
DFNA11 |
11q13.5 |
||
MYO15 |
Myosin XV |
DFNB3 |
17p11.2 |
||
| OTOA | 607038 | otoancorin | DFNB22 | 16p12.2 |
Zwaenepoel et al. 2002 |
OTOF |
Otoferlin |
DFNB9 |
2p23.3 |
||
PCDH15 |
Protocadherin 15 |
DFNB23 |
10q21-q22 |
||
PDS/SLC26A4 |
Pendrin |
DFNB4 |
7q31.1 |
Li
et al. 1998 |
|
POU4F3 |
POU4F3 |
DFNA15 |
5q32 |
||
POU3F4 |
POU3F4 |
DFN3 |
Xq21 |
||
SLC26A5 |
Prestin |
|
7q22.1 |
||
STRC |
Stereocilin | DFNB16 |
15q15 |
Verpy et al. 2001 | |
TECTA |
Alpha-Tectorin |
DFNA8/12 |
11q23.3 |
||
TFCP2L3 |
|
Unknown |
DFNB28 |
8q22 |
|
| TMC1 | 606706 | TMC1 | DFNA36 DFNB7/B11 |
9q21.13 |
Kurima
et al. 2002 Vreugde et al. 2002 |
| TMIE | 607237 | TMIE (transmembrane inner ear expressed gene) | DFNB6 DFNA36 |
3p21 |
Mitchem et al. 2000 Naz et al. 2002 |
TMPRSS3 |
Transmembrane protease, serine 3 |
DRNB8/10 |
21q22 |
||
| WFS1 | 606201 | Wolframin | DFNA6/14 | 4p16.1 |
Bespalova et al. 2001 |
| WHRN | 607928 | CASK | DFNB31 | 9q32 |
Mburu et al. 2003 Yap et al. 2003 |
Table 2 and Table 3 provides genetic and clinical information for NSDHL and NSRHL, respectively. In Tables 2 and 3 the columns are as follows: 1) locus name (hot link to OMIM entry); 2) chromosomal location; 3) the gene; 4) origin of families which have shown linkage to a particular locus; 5) age of onset; 6) evolution of hearing loss; 7) affected frequencies; and 8) most important reference(s).
Table 2: Identified Autosomal Dominant Loci for Non-sydromic Hearing
Loss. Table 2
Locus |
Location |
Gene |
Origin of Families |
Onset |
Evolution |
Affected Frequencies |
Most Important Reference(s) |
DFNA1 |
5q31 |
DIAPH1 |
Costa Rica |
5-20 yrs |
Progressive starting in the low frequencies |
All |
|
DFNA2 (600101) |
1p34 |
GJB3 |
Indonesia, USA, Belgium, Netherlands |
Decade 1-3 |
Progressive to severe hearing loss |
High, progressive to low |
|
DFNA3 (601544) |
13q12 |
GJB2 |
France |
Prelingual |
Stable or progressive, moderate to severe hearing loss |
All, greatest in high frequencies |
Chaib et al. 1994; Kelsell et al. 1997; Denoyelle et al. 1998 |
DFNA4 |
19q13 |
unknown |
USA |
Decade 3-4 |
Slow or rapid progression to severe hearing loss |
High, progressive to low |
|
DFNA5 |
7p15 |
DFNA5 |
Netherlands |
Decade 1-3 |
Progressive to severe hearing loss |
High, progressive to low |
|
DFNA6 (600965) |
4p16.1 |
WFS1 |
USA (Irish descent), Netherlands |
Decade 1-2 |
Slowly Progressive |
Low, Progressive to high |
Lesperance
et al. 1995 |
DFNA7 |
1q21-q23 |
unknown |
Norway |
Decade 1-2 |
Progressive |
High, Progressive to low |
|
11q22-24 |
TECTA |
Austria, |
Prelingual |
Moderate to profound, non-progressive |
All |
||
DFNA9 |
14q12-q13 |
COCH |
USA, Austria, Belgium, Nertherlands |
~20 or ~40 yrs |
Progressive to profound hearing loss, starting in the high frequencies |
All |
Manolis
et al. 1996; |
DFNA10 |
6q22-q23 |
EYA4 |
USA, Belgium |
Decade 2-4 |
Postlingual, slow or rapid progression to severe hearing loss |
All |
|
DFNA11 |
11q12.3-q21 |
MYO7A |
Japan |
Postlingual, 1st Decade |
Moderate, progressive |
All |
|
DFNA13 |
6p21 |
COL11A2 |
USA, Dutch |
Decade 2-4 |
Nonprogressive, predominantly affects middle frequencies |
All |
|
DFNA14 |
4p16.1 |
WFS1 |
Dutch, USA (Irish descent) |
Decades 1-2 |
Stops short of profound deafness |
low and mid frequencies |
|
DFNA15 (602459) |
5q31 |
POU4F3 |
Israel |
18-30 yrs of age |
Progreessive hearing loss, moderate to severe by age 50 |
All |
|
DFNA16 |
2q24 |
unknown |
Japan |
|
Progressive hearing loss, Mild to Moderate |
Affecting mainly the high frequencies |
|
DFNA17 (603622) |
22q |
MYH9 |
USA |
1st decade of life |
Progressive to moderate to severe by the 3rd decade of life |
|
|
DFNA18(606012) |
3q22 |
unknown |
Germany |
1st decade of life |
severe progressive |
All |
|
DFNA19 |
10 pericentromeric |
unknown |
|
|
|
|
Green et al. 1998 |
DFNA20/26 (604717) |
17q25 |
ACTG1 |
USA |
13-25 yrs |
Progressive, first evident at 6-8 KHz |
All |
|
DFNA22 (606346) |
6q13 |
MYO6 |
Italy |
childhood |
progressive, postlingual |
|
|
DFNA23 |
14q21-q22 |
unknown |
Switzerland |
prelingual |
Stable or progressive |
Low, mid and high frequencies, moderate to profound |
|
DFNA24 |
4q35-qter |
unknown |
Switzerland |
prelingual |
nonprogressive |
Affecting mainly the mid to high frequencies |
|
DFNA25 |
12q21-24 |
unknown |
Czech Republic |
1st two decades of life |
progressive |
high frequencies |
|
DFNA27 |
4q12 |
unknown |
|
11-29 yrs. |
Progreessive hearing loss, moderate to severe by age 40 |
|
|
DFNA28 |
8q22 |
TFCP2L3 |
USA |
postlingual |
Progreessive hearing loss, moderate to severe by age 40. |
high or mid-frequencies |
|
DFNA30 |
15q26 |
unknown |
Italy |
end of 1st decade of life |
Rapid progression to moderate to severe until the 4th decade of life |
mid and high frequencies |
|
DFNA32 |
11p15 |
unknown |
USA |
Progressive hearing loss |
|||
DFNA34 |
1q44 |
unknown |
3rd or 4th decade |
Slow progressive rate |
|||
DFNA36 |
9q13-q21 |
TMC1 |
USA |
1st decade | Rapidly progresses to profound by early adulthood |
||
DFNA37 |
1p21 |
unknown |
USA |
prelingual |
High progressing to low |
||
DFNA39 |
4q21.3 |
DSPP |
Chinese |
3rd and 5th decade |
Progressive, moderate to severe |
progressive high frequency and low |
|
DFNA41 |
12q24-qter |
unknown |
Chinese |
after their teens |
Progressive, from moderate to profound loss |
All |
|
DFNA43 |
2q12 |
unknown |
Italian |
second decade of life |
Subsequent gradual progression from moderate to profound loss |
All |
|
DFNA44 |
3q28-29 |
unknown |
Spanish |
|
Bilateral and progressive |
|
|
DFNA47 |
9p21-22 |
unknown |
Italian |
after their teens |
Progressive, subsequent gradual progression to a moderate-severe loss |
|
|
DFNA48 |
12q13-q14 |
unknown |
Italian |
|
|
|
Table 3: Identified Autosomal Recessive Loci for Non-sydromic Hearing Loss.Table 3
Locus |
Location |
Gene |
Origin of Families |
Onset |
Evolution |
Affected Frequencies |
Most Important Reference(s) |
DFNB1 (220290) |
13q12 |
GJB2 |
Tunisia, Israel (Bedouin), Pakistan, Australian |
Usually prelingual |
Stable, severe-to-profound loss |
All |
|
DFNB2 (600060) |
11q13.5 |
MYO7A |
Tunisia |
Birth-16yrs |
Stable, profound |
All |
|
DFNB3 (600316) |
17p11.2-q12 |
MYO15 |
Bali, India |
Congenital |
Stable, profound |
All |
|
DFNB4 (600791) |
7q31 |
PDS |
Israel (Druze) |
Congenital |
Stable, severe-to-profound |
All |
|
DFNB5 |
14q12 |
unknown |
India |
Congenital |
Stable, Severe-to-profound loss |
All |
|
DFNB6 (600971) |
3p14-p21 |
TMIE |
India |
Congenital |
Stable, Severe-to-profound loss |
All |
|
DFNB7/11 (600974) |
9q13-q21 |
TMC1 |
India, Israel (Bedouin) |
Congenital |
Stable, Severe-to-profound loss/ Profound |
All |
|
DFNB8/10 (601072) |
21q22 |
TMPRSS3 |
Pakistan, Israel (Palestinian) |
10-12yrs/ Congenital |
Progressive to severe hearing loss/ Stable, severe loss |
All |
|
DFNB9 (601071) |
2p22-p23 |
OTOF |
Lebanon, Turkey |
Congenital |
Stable, profound |
All |
|
DFNB12 (601386) |
10q21-22 |
CDH23 |
Syrian |
Congenital |
Stable, profound |
All |
|
DFNB13 (603098) |
7q34-36 |
unknown |
Lebanon |
Prelingual |
Severe progressive |
|
|
DFNB14 (603678) |
7q31 |
unknown |
Lebanon |
Prelingual |
Profound |
||
DFNB15 (601869) |
3q21-q25 |
unknown |
India |
Prelingual |
Stable |
All |
|
DFNB16 (603720) |
15q15 |
STRC |
Pakistan, Palistine, Syria, |
3-5 years |
Non-progressive, moderate mid frequencies and severe high frequencies |
All |
|
DFNB17 (603010) |
7q31 |
unknown |
India, Middle Eastern Druze |
Prelingual |
Profound |
All |
|
DFNB18 (602092) |
11p14-15.1 |
USH1C |
India |
|
Profound |
|
|
DFNB19 |
18p11 | unknown |
|
Congenital |
Profound |
All |
Green et al. 1998 |
DFNB20 (604060) |
11q25-qter |
unknown |
Pakistan |
3 months ~ 1 year of age |
Profound |
All |
|
DFNB21 (603629) |
11q |
TECTA |
Lebanon |
Prelingual |
Profound |
Moderately severe ~ all |
|
DFNB22 (607038) |
16p12.2 |
OTOA |
Palestine |
Profound |
|
||
DFNB23 |
10p11.2-q21 |
PCDH15 |
|
|
|
|
|
DFNB24 |
11q23 |
unknown |
|
|
|
|
Richard Smith, unpublished |
DFNB25 |
4p15.3-q12 |
unknown |
|
|
|
|
Richard Smith, unpublished |
DFNB26 (605428) |
4q31 |
unknown |
Pakistan |
Prelingual |
Profound |
All |
|
| DFNB27 (605818) |
2q23-q31 |
unknown |
United Arab Emirate |
Pulleyn et al. 2000 | |||
DFNB28 |
22q13 |
unknown |
Palestine |
Prelingual |
Profound |
|
|
DFNB29 |
21q22 |
CLDN14 |